Celgene has today confirmed that it will acquire Juno Therapeutics for $9 billion, and says the move will make it a leader in cell immunotherapy. The price is a significant premium on the $5.5 bn ...

Judge Bars Musk Team From Treasury Systems, Warning of ‘Irreparable Harm’ The judge’s order, a response to a lawsuit filed by 19 state attorneys general, creates a situation that could pose ...